This contract expires in 239 days (Jan 31, 2027).

Browse related active opportunities

COST SHARINGNO SET ASIDE USED.

VEDANTA BIOSCIENCES, INC. - TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.

PIID: 75A50120C00177Solicitation ID: BAA-18-100-SOL-00003
Signed Date: Dec 3, 2025Effective Date: Sep 28, 2020End Date: Closes in 239 days
Award $
$79.1M
Vendor
VEDANTA BIOSCIENCES, INC.
NAICS
541714
Signed Date
Dec 3, 2025

Key Details

Dollars Obligated
$79.1M
Base & All Options
Awarding Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Product Service Code
AZ13 - R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT)
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
BOSTON, MA, 021161501, CD-MA-08

Description

TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.

Context & Analysis

On Dec 3, 2025, Department of Health and Human Services obligated $79,146,088 to VEDANTA BIOSCIENCES, INC. for to develop medical countermeasures (mcms) that treat antibiotic resistant infections.. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost sharing contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BOSTON, MA. The contract is scheduled through Jan 31, 2027 — approximately 8 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.

Contractor Information

UEI: C91JJXT9QND5
CAGE Code: 6DGY3
Location: BOSTON, MA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related